U.S. Markets open in 6 hrs 44 mins

ScoutCam Inc. (SCTC)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
1.00000.0000 (0.00%)
At close: 2:25PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close1.0000
Open1.0500
BidN/A x N/A
AskN/A x N/A
Day's Range1.0000 - 1.0000
52 Week Range0.7400 - 1.1800
Volume13,605
Avg. Volume5,813
Market Cap34.733M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • ScoutCam Appoints Professor Jacob Bortman, Brigadier General (Ret.) Head of Material Directorate of the Israeli Air Force as Director of Business Development Industry 4.0
    GlobeNewswire

    ScoutCam Appoints Professor Jacob Bortman, Brigadier General (Ret.) Head of Material Directorate of the Israeli Air Force as Director of Business Development Industry 4.0

    OMER, Israel, Feb. 18, 2021 (GLOBE NEWSWIRE) -- ScoutCam (OTCQB:SCTC), a leading developer and manufacturer of customized micro visual solutions and supplementary technologies, today announced the appointment of Professor Jacob Bortman as director of its business development in the field of Industry 4.0. Prof. Bortman brings to ScoutCam an accomplished military background where he reached the rank of Brigadier General (Ret.) in the Israeli Air Force (IAF). Prof. Bortman most recently held the post of IAF’s Head of Material Directorate, where he oversaw the maintenance of all IAF aircraft, and prior to that served as both its Head of the Aircraft Department and Head of the UAV and Space Department. Following his retirement from the IAF, Prof. Bortman transitioned to academia where he now teaches and researches as a professor of mechanical engineering at Ben-Gurion University in Israel. Prof. Bortman will help ScoutCam identify business opportunities in the fields of maintenance and predictive maintenance in order to help maximize the business and market value of some of the Company’s most lucrative proprietary technologies, including its highly resilient micro-video cameras, wired and wireless transmission technologies and more. Prof. Bortman cited several of ScoutCam’s recently publicized achievements within his industry of expertise as reasons for why he was drawn to the Company, including NASA’s use of ScoutCam’s cameras in orbit, ScoutCam securing a global tender issued by the US Government to provide NASA with micro video cameras and appearing on the US government’s list of approved suppliers. In particular, Prof. Bortman underscored that “the use of ScoutCam’s micro-video cameras as sensors in the Industry 4.0 market may help transform and expand the financial opportunities in the predictive maintenance market. That ScoutCam’s cameras were proven, in a NASA mission, to be highly resistant under extreme, extra-terrestrial conditions (minus 127 degrees centigrade, cosmic radiation, extreme vibrations and vacuum) signals to me that ScoutCam’s products are equipped with the level of ingenuity and quality necessary for succeeding in sectors such as aerospace, renewable energy, atomic energy and more.“ “We are excited to join forces with Prof. Bortman and to tap into his unique expertise” said Dr. Yaron Silberman, Chief Executive Officer of ScoutCam. “Here at ScoutCam, we view Industry 4.0 as a lucrative and enticing new frontier for the application of our technologies, and Prof. Bortman allows us to enter the space with a competent and vastly experienced guide.” About ScoutCamScoutCam is a leading provider of customized visual solutions for organizations across a variety of industries in the form of highly resistant micro cameras and supplementary technologies. ScoutCam devices are used across the medical, aerospace, industrial, research and defense industries. For more information please visit: https://www.scoutcam.com Media ContactYaron Silbermaninfo@scoutcam.com +972 526 511 122 Cautionary Note Regarding Forward-Looking Statements Information set forth in this news release contains forward-looking statements that are based on the Company’s expectations, beliefs, assumptions and intentions regarding, among other things, its product-development efforts, business, financial condition, results of operations, strategies or prospects, as of the date of this news release. They are not guarantees of future performance. Forward-looking statements can be identified by the use of forward-looking words such as “believe,” “expect,” “intend,” “plan,” “may,” “should” or “anticipate” or their negatives or other variations of these words or other comparable words or by the fact that these statements do not relate strictly to historical or current matters. The Company cautions that all forward-looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company's control. Such factors include, among other things, our ability to maximize the economic potential and monetize the technology covered in the press release; the material and positive effect Professor Jacob Bortman’s appointment will have on our business and operations, specifically in the area of Industry 4.0; our ability to succeed, operationally and monetarily, in the Industry 4.0 sector as well as other industries and sectors described in the press release; risks and uncertainties relating to our reliance on third-party suppliers; market acceptance of our products by prospect markets and industries; our ability to raise sufficient funding in order to meet our business and financial goals; and certain other factors summarized in our filings with the Securities and Exchange Commission. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward looking information. Except as required under applicable securities legislation, the Company undertakes no obligation to publicly update or revise forward-looking information.

  • Medigus: Leading Life Science and Pharmaceutical Entrepreneur Mori Arkin to Join ScoutCam’s Board of Directors
    GlobeNewswire

    Medigus: Leading Life Science and Pharmaceutical Entrepreneur Mori Arkin to Join ScoutCam’s Board of Directors

    OMER, Israel, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions and innovative internet technologies, announced today that ScoutCam Inc. (OTCQB: SCTC), Medigus’ subsidiary and a leading developer and manufacturer of customized micro visual solutions and supplementary technologies, that Mr. Mori Arkin has been appointed to its board of directors. On May 18, 2020, Mr. Arkin invested $2 million in ScoutCam through his investment company, Arkin Holdings, and, in connection with the investment, appointed Dr. Irit Yaniv as a ScoutCam’s board member and representative of Arkin Holdings. After carefully observing ScoutCam’s positive momentum over the past several months, including in his capacity as a special advisor to ScoutCam on matters related to intellectual property, Mr. Arkin decided to replace Dr. Yaniv and represent Arkin Holdings on the board himself. Prof. Benad Goldwasser, the Executive Chairman of Scoutcam’s board, expressed his gratitude to Dr. Yaniv for her contribution. At the same time, he thanked Mr. Arkin for taking this momentous step of assuming an active role on the board of ScoutCam and thereby demonstrating his belief in ScoutCam and its growing potential. Mr. Arkin said “My decision to formally join the ScoutCam board reflects my growing belief in this company and its potential, including beyond visualization solutions for the medical industry. ScoutCam, in my mind, has only begun to tap into its vast potential, and that the applications of its technology are limitless, whether in the fields of maintenance and predictive maintenance, a critical pillar of Industry 4.0, aviation and defense, and more. I am excited to take a more active role on the company’s leadership team to help realize this impressive potential.” Founder and Chairman of Arkin Holdings, Moshe “Mori” Arkin, is one of Israel’s most successful life sciences and pharmaceutical entrepreneurs. A renowned industrialist and generic drug specialist, he founded Arkin Holdings, which owns, among other investments, a healthcare portfolio of $1 billion through various investment arms, with holdings in some 20 companies, many of them Israeli companies, developing pharmaceutical drugs and medical equipment, such as UroGen Pharma, Keros Therapeutics and Novolog. Mori previously grew Agis into a leading pharmaceutical company and sold it to Perrigo in 2005 for $818 million. About Medigus Medigus is traded on the Nasdaq Capital Market. To learn more about the company’s advanced technology, please visit www.medigus.com. Cautionary Note Regarding Forward Looking Statements This press release may contain statements that are “Forward-Looking Statements,” which are based upon the current estimates, assumptions and expectations of Medigus’ management and its knowledge of the relevant market. The company has tried, where possible, to identify such information and statements by using words such as “anticipate,” “believe,” “envision,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “project,” “target,” “potential,” “will,” “would,” “could,” “should,” “continue,” “contemplate” and other similar expressions and derivations thereof in connection with any discussion of future events, trends or prospects or future operating or financial performance, although not all forward-looking statements contain these identifying words. For example, Medigus uses forward looking statements when describing ScoutCam’s ability to maximize the economic potential and monetize the technology covered in the press release and the material and positive effect Mr. Arkin’s appointment will have on ScoutCam’s business and operations. These forward-looking statements represent Medigus’ expectations or beliefs concerning future events, and it is possible that the results described in this press release will not be achieved, due to inter alia the spread of COVID-19 as well as the restriction deriving therefrom and difficulties arising from the development and manufacture of wireless charging products. Nothing in the description herein should be understood or construed as an announcement of completed products or an existing proof of concept. By their nature, Forward-Looking Statements involve known and unknown risks, uncertainties and other factors which may cause future results of the Medigus’ activity to differ significantly from the content and implications of such statements. Other risk factors affecting Medigus are discussed in detail in the Medigus’ filings with the Securities and Exchange Commission. Forward-Looking Statements are pertinent only as of the date on which they are made, and Medigus undertakes no obligation to update or revise any Forward-Looking Statements, whether as a result of new information, future developments or otherwise. Neither Medigus nor its shareholders, officers and employees, shall be liable for any action and the results of any action taken by any person based on the information contained herein, including without limitation the purchase or sale of Medigus’ securities. Nothing in this press release should be deemed to be medical or other advice of any kind. Contact (for media only)Oz Adler Chief Financial Officer +972-8-6466-880 ir@medigus.com

  • Leading Life Science and Pharmaceutical Entrepreneur Mori Arkin to Join ScoutCam's Board of Directors
    GlobeNewswire

    Leading Life Science and Pharmaceutical Entrepreneur Mori Arkin to Join ScoutCam's Board of Directors

    OMER, Israel, Feb. 16, 2021 (GLOBE NEWSWIRE) -- ScoutCam (OTCQB:SCTC), a leading developer and manufacturer of customized micro visual solutions and supplementary technologies, today announced that Mr. Mori Arkin has been appointed to its board of directors. On May 18, 2020, Mr. Arkin invested $2 million in the Company through his investment company, Arkin Holdings, and, in connection with the investment, appointed Dr. Irit Yaniv as a board member and representative of Arkin Holdings. After carefully observing ScoutCam’s positive momentum over the past several months, including in his capacity as a special advisor to ScoutCam on matters related to intellectual property, Mr. Arkin decided to replace Dr. Yaniv and represent Arkin Holdings on the board himself. Prof. Benad Goldwasser, the Executive Chairman of the Board, expressed his gratitude to Dr. Yaniv for her contribution. At the same time, he thanked Mr. Arkin for taking this momentous step of assuming an active role on the board of ScoutCam and thereby demonstrating his belief in the Company and its growing potential. Mr. Arkin said "My decision to formally join the ScoutCam board reflects my growing belief in this Company and its potential, including beyond visualization solutions for the medical industry. ScoutCam, in my mind, has only begun to tap into its vast potential, and that the applications of its technology are limitless, whether in the fields of maintenance and predictive maintenance, a critical pillar of Industry 4.0, aviation and defense, and more. I am excited to take a more active role on the Company’s leadership team to help realize this impressive potential." Founder and Chairman of Arkin Holdings, Moshe “Mori” Arkin, is one of Israel’s most successful life sciences and pharmaceutical entrepreneurs. A renowned industrialist and generic drug specialist, he founded Arkin Holdings, which owns, among other investments, a healthcare portfolio of $1 billion through various investment arms, with holdings in some 20 companies, many of them Israeli companies, developing pharmaceutical drugs and medical equipment, such as UroGen Pharma, Keros Therapeutics and Novolog. Mori previously grew Agis into a leading pharmaceutical company and sold it to Perrigo in 2005 for $818 million. About ScoutCamScoutCam is a leading provider of customized visual solutions for organizations across a variety of industries in the form of highly resistant micro cameras and supplementary technologies. ScoutCam devices are used across the medical, aerospace, industrial, research and defense industries. For more information please visit: https://www.scoutcam.com Media ContactYaron Silbermaninfo@scoutcam.com +972 526 511 122 Cautionary Note Regarding Forward-Looking Statements Information set forth in this news release contains forward-looking statements that are based on the Company’s expectations, beliefs, assumptions and intentions regarding, among other things, its product-development efforts, business, financial condition, results of operations, strategies or prospects, as of the date of this news release. They are not guarantees of future performance. Forward-looking statements can be identified by the use of forward-looking words such as “believe,” “expect,” “intend,” “plan,” “may,” “should” or “anticipate” or their negatives or other variations of these words or other comparable words or by the fact that these statements do not relate strictly to historical or current matters. The Company cautions that all forward-looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company's control. Such factors include, among other things, our ability to maximize the economic potential and monetize the technology covered in the press release; the material and positive effect Mr. Arkin’s appointment will have on our business and operations; risks and uncertainties relating to our reliance on third-party suppliers; market acceptance of our products by prospect markets and industries; our ability to raise sufficient funding in order to meet our business and financial goals; and certain other factors summarized in our filings with the Securities and Exchange Commission. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward looking information. Except as required under applicable securities legislation, the Company undertakes no obligation to publicly update or revise forward-looking information.